a public good project by the
Synthesis
Company
of California

© 2026

Irwin D. Bernstein | doi.page

0 works0 citations0 h-index

Irwin D. Bernstein

Publications by Year

Research Areas

Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction, Zebrafish Biomedical Research Applications

Most-Cited Works

→ Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse(2001)883 cited
→ Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution(2010)764 cited
→ Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells(2010)659 cited
→ Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support(1993)650 cited
→ Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling(2000)635 cited
→ Antigen CD34+ marrow cells engraft lethally irradiated baboons.(1988)590 cited

→ Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia(2001)

583 cited

→ Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia(2001)516 cited

→ Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate(1999)456 cited

→ Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence(2005)451 cited